Robert Ross: I am thrilled to announce the launch of Clasp Therapeutics

Robert Ross, Chief Executive Officer at Clasp Therapeutics, announced on LinkedIn:

“I am thrilled to announce the launch of Clasp Therapeutics and to be part of a hardworking and dedicated team that will generate meaningful impact for people by transforming what is possible in immuno-oncology. Based on the brilliant work of our scientific founders Bert Vogelstein and Drew Pardoll, our T cell engagers have the potential to achieve high-precision anti-tumor activity without off-target reactivity, thus extending the number of patients and hard-to-treat tumor types we can reach with immune-directed therapies.

I want to thank our founders, our team, and our many investors for building Clasp from the ground up, and I look forward to what we can collectively achieve for patients.”

Source: Robert Ross/LinkedIn